(Q35157513)

6 August 2017

title

Chronic idiopathic slow transit constipation: pathophysiology and management (English)

1 reference

6 August 2017

1 reference

El-Salhy M

1

1 reference

6 August 2017

publication date

1 July 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

5

1 reference

6 August 2017

issue

4

1 reference

6 August 2017

page(s)

288-296

1 reference

Irritable bowel syndrome: a little understood organic bowel disease?

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1318.2003.00498.X

Selective autonomic and sensory deficits in slow transit constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1318.2003.00498.X

Slow transit constipation: a disorder of pelvic autonomic nerves?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1318.2003.00498.X

W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1318.2003.00498.X

Mutation of the proto-oncogene c-kit blocks development of interstitial cells and electrical rhythmicity in murine intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1318.2003.00498.X

Abnormal colonic endocrine cells in patients with chronic idiopathic slow-transit constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1318.2003.00498.X

Proximal and distal gut hormone secretion in slow transit constipation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1318.2003.00498.X

Postprandial gut peptide plasma levels in women with idiopathic slow-transit constipation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1318.2003.00498.X

Plasma cholecystokinin, plasma peptide YY and gallbladder motility in patients with slow transit constipation: effect of intestinal stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1318.2003.00498.X

Role of nitric oxide in the colon of patients with slow-transit constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1318.2003.00498.X

Chronic idiopathic constipation: pathophysiology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1318.2003.00498.X

Serotonergic modulating drugs for functional gastrointestinal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1318.2003.00498.X

Effect of prucalopride, a new enterokinetic agent, on gastrointestinal transit and anorectal function in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1318.2003.00498.X

Prucalopride, a systemic enterokinetic, for the treatment of constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1318.2003.00498.X

Outcome of colectomy for slow transit constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1318.2003.00498.X

Clinical management of intractable constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1318.2003.00498.X

Outcome and predictors of success of biofeedback for constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1318.2003.00498.X

Response to a behavioural treatment, biofeedback, in constipated patients is associated with improved gut transit and autonomic innervation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1318.2003.00498.X

Nitric oxide as an inhibitory non-adrenergic non-cholinergic neurotransmitter

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1318.2003.00498.X

10.1046/J.1463-1318.2003.00498.X

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference